Walleye Capital’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$744K Buy
41,200
+31,200
+312% +$598K ﹤0.01% 3740
2026
Q2
$187K Buy
+10,000
New +$145K ﹤0.01% 3549
2023
Q3
– Sell
-100
Closed -$1.26K – 5254
2023
Q2
$1.26K Buy
+100
New +$1.24K ﹤0.01% 4187

Other funds holding RLAY

Walleye Capital's RLAY Position: Q3 2026 in Review

Walleye Capital opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 100 shares worth $1.8K. The stake represents ﹤0.01% of the portfolio and ranks #5848 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RLAY as recently as Q1 2025.

Walleye Capital first reported a position in RLAY in Q3 2022 and has held it in 8 quarters since. The position peaked at $12.9M in Q3 2024. 261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Walleye Capital held 100 shares of Relay Therapeutics worth $1.8K as of Q3 2026.
  • Relay Therapeutics was a new Walleye Capital position in Q3 2026.
  • Relay Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5848 holding.
  • Walleye Capital first reported a position in Relay Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • Walleye Capital's Relay Therapeutics position peaked at $12.9M in Q3 2024.
  • 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.